Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
28 Cards in this Set
- Front
- Back
how would you treat coag neg staph catheter infection?
|
remove catheter and treat x 5-7 days with IV antibiotics, if catheter retained treat with IV antibiotics for 10-14 days plus antibiotic lock
|
|
how would you treat staph aureus related catheter infection?
|
remove catheter and treat 7-14 days with IV antibiotics
|
|
how would you treat enterococcus related catheter related infection
|
remove catheter and treat 7-14 days with IV antibiotics
|
|
how would you treat gram - bacilli related catheter infectiond?
|
remove catheter and treat 7-14 days with IV antibiotics
|
|
how would you treat candida species related catheter infections?
|
remove catheter and treat with antifungal for 14 days after first negative culture
|
|
how would you treat a complicated catheter infection?
|
remove catheter and treat for 4-6 weeks (IV antibiotics)
|
|
MSSA (complicated catheter infection)
1. preferred therapy (2) 2. alternative therapy (2) |
1. nafcillin, oxacillin
2. cefazolin, vancomycin **penicillinase-resistant Pen or cephalosporin are preferred to vancomycin |
|
MRSA (complicated catheter infection)
1. preferred therapy (1) 2. alternative therapy (1) |
1. vancomycin
2. daptomycin 6-8 mg/kg/day **linezolid not recommended for empiric therapy (static drug-poor outcome) |
|
CoNS (Meth Susceptible) (complicated catheter infection)
1. preferred therapy (2) 2. alternative therapy (1) |
1. nafcillin, oxacillin
2. vancomycin **some do not use naf or ox in this case and will use vanco regardless of susceptiblity due to heteroresistance |
|
CoNS (Meth resistant) (complicated catheter infection)
1. preferred therapy (1) 2. alternative therapy (1) |
1. vancomycin
2. daptomycin |
|
Enterococcus (complicated catheter infection) non amp resistant
1. preferred therapy (1) 2. alternative therapy (1) |
1. ampicillin with or without gentamicin
2. vancomycin |
|
Enterococcus (complicated catheter infection) amp resistant
1. preferred therapy (1) 2. alternative therapy (1) |
1. vancomycin with or without gentamicin
2. daptomycin |
|
VRE (complicated catheter infection)
1. preferred therapy (1) 2. alternative therapy (2) |
1. daptomycin
2. linezolid, synercid (quinupristin/dalfopristin) |
|
risk factors for developing infective endocarditis (IE) (8)
|
1. structural heart disease (congenital or acquired)
2. rheumatic heart disease 3. prosthetic valve 4. mitral valve prolapse with regurgitation 5. ateriovenous fistulae 6. intravascular devices 7. pacemakers 8. IV drug use |
|
microorganisms that adhere to NBTE (endothelium and valves) more avidly then others (5)
|
1. enterococci
2. viridans streptococci 3. s. aureus 4. s. epidermis 5. p. aeruginosa |
|
how to antibiotics prevent IE? (2)
|
1. kill bacteria
2. inhibit adhesion |
|
gram - bacilli are usually isolated in endocarditis in which patients (4)
|
1. IVDAs
2. hospitalized patients 3. individuals with prosthetic valves (less than 1 year following surgery) 4. patients with cirrhosis |
|
commonly isolated gram - bacilli from NBTE (6)
|
1. salmonella
2. ecoli 3. serratia marcescens 4. pseudomonas aeruginosa 5. burkholderia cepacia 6. HACEK microorganisms (haemophilus parainfluenzae, h. influenzae, actinobacillus actinomycetemcomittans, cardiobacterium hominis, ekenella corrodens, kingella kingae) |
|
how long is the incubation period generally for patients with IE
|
less than 2 weeks
|
|
sx of IE (15)
|
1. fever (80%)
2. night sweats 25 3. weight loss 25 4. heart murmur 85% (new 3-5%; changing murmur 5-10%) 5. embolic pneumonia 50+% 6. stroke 7. skin lesions 8. chills 9. anorexia 10. malaise 11. weakness 12. myalgia and arthralgia 13. splenomegaly 14. dyspnea 15. back pain |
|
small painful nodular lesions found on the pads of the fingers or toes. disappears within hours (10-23%)
|
osler nodes
|
|
red/brown streaks found in the nails (15%)
|
splinter hemorrhages
|
|
initially red, nonblanching lesions found in the conjuctivae, buccal mucosa, palate, and extremeties (20-40%)
|
pectechiae
|
|
hemorrhagic, macular, painless lesions found on the palms and soles. persists for days (less than 10%)
|
Janeway lesions
|
|
oval, pale, retinal lesions surrounded by hemorrhage (10%)
|
roth spots
|
|
factors associated with increased mortality with IE (5)
|
1. CHF
2. culture negative endocarditis 3. endocarditis caused by resistant organisms (fungi or gram - bacteria) 4. left sided endocarditis caused by s. aureus 5. prosthetic valve endocarditis |
|
indications for surgical interventions in IE patients (6)
|
1. patient develops CHF
2. valvular obstruction 3. local suppurative complications due to myocaridal abscess 4. endocarditis caused by resistant microorganism (fungi or gram-) 5. early prosthetic valve endocarditis 6. perisistent bacteremia or other evidence of failure or appropriate medical therapy |
|
which high risk patients should receive prophylaxis against IE (4)
|
1. patients with prosthetic valves
2. patients with hx of IE 3. most patients with congenital heart disease 4. cardiac transplantation recipients who develop cardiac valvulopathy |